← Back to Search

Other

Bone Broth Diet for Weight Loss in Obesity

N/A
Waitlist Available
Led By David Crowley, MD
Research Sponsored by Veyl Ventures LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 22, day 28, day 50, day 56
Awards & highlights

Summary

This trial tests how safe and effective a bone broth diet is for weight loss in obese adults. It measures safety, weight, and BMI at two points.

Who is the study for?
Adults aged 35-65 with obesity (BMI between 30.0 and 39.9) who haven't had major surgery recently or plan to during the study, don't smoke, aren't drug/alcohol abusers, have stable weight for the past three months, and are not on medications affecting weight. Women must be non-childbearing or use birth control; men with vasectomy qualify.Check my eligibility
What is being tested?
The trial is testing Dr. Kellyann's Bone Broth Diet to see if it helps obese adults lose weight safely. Participants will follow the diet and their weight loss and BMI changes will be tracked at specific intervals while monitoring for any adverse events.See study design
What are the potential side effects?
Potential side effects may include digestive issues due to dietary changes but specifics aren’t listed in the provided information. Safety will be monitored by recording any adverse events that occur during the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 22, day 28, day 50, day 56
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 22, day 28, day 50, day 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The change in body mass index (BMI) from baseline at Days 22 and 50 following the bone broth diet.
The change in weight from baseline at Days 22 and 50 following the bone broth diet.
Secondary outcome measures
The change in android/gynoid fat ratio from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
The change in arm circumference from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
The change in blood glucose levels from baseline at Days 22, 28, and 50 and from Day 28 at Day 50 following the bone broth diet.
+17 more
Other outcome measures
Blood pressure (BP) at screening, baseline, day 22, day 28, and day 50 following the bone broth diet.
Creatinine measurement at screening, day 22, and day 50 following the bone broth diet.
Estimated glomerular filtration rate (eGFR) at screening day 22, and day 50 following the bone broth diet.
+26 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dr. Kellyann's Bone BrothExperimental Treatment1 Intervention
During the bone broth phases, each week will be separated into 'fasting days' and 'feeding days'. There will be 2 non-consecutive fasting days and 5 feeding days per week. On fasting days, participants will be instructed to consume 1 packet of bone broth every 2 hours, for a total of 7 packets/day. On feeding days, participants will consume 3 meals/day, made up of 'Yes' foods portioned according to instructions provided in the Bone Broth Diet Quick Reference Guide and 1 packet of bone broth, twice a day, as snacks between meals. If a bone broth serving is missed participants are instructed to consume the serving as soon as they remember. Participants will be advised not to exceed 7servings of bone broth on fasting days and 2 servings on feeding days. During the maintenance phase, participants will not consume any bone broth.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common weight loss treatments, such as the Bone Broth Diet, primarily work by creating a caloric deficit, which encourages the body to burn stored fat for energy. These nutritional interventions often include low-calorie, nutrient-dense foods that promote satiety and reduce overall caloric intake. Some diets may also incorporate elements that improve metabolic health, such as balanced macronutrient distribution and anti-inflammatory ingredients. Understanding these mechanisms is important for weight loss patients as it helps them select effective and sustainable dietary plans that support their long-term health and weight management goals.

Find a Location

Who is running the clinical trial?

Veyl Ventures LLCLead Sponsor
KGK Science Inc.Industry Sponsor
78 Previous Clinical Trials
6,060 Total Patients Enrolled
David Crowley, MDPrincipal InvestigatorKGK Science Inc.
35 Previous Clinical Trials
2,653 Total Patients Enrolled

Media Library

Dr. Kellyann's Bone Broth (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05740670 — N/A
Weight Loss Research Study Groups: Dr. Kellyann's Bone Broth
Weight Loss Clinical Trial 2023: Dr. Kellyann's Bone Broth Highlights & Side Effects. Trial Name: NCT05740670 — N/A
Dr. Kellyann's Bone Broth (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05740670 — N/A
~40 spots leftby Jul 2025